Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate in Basal Cell Carcinoma
NCT03546166Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jul 2018
- Primary completion
- Mar 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in basal cell carcinoma (BCC), sponsored by Centre Hospitalier Universitaire de Nice. Started Jul 2018; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT03546166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03546166.